...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: I called E trade this morning 10/20/2020

"And fuzzy pipe down for Pete's sakes."

Maybe try following your own advice for goodness sakes.

Share
New Message
Please login to post a reply